MedPath
HSA Approval

PEXITAZ 500 POWDER FOR SOLUTION FOR INJECTION 500MG/VIAL

SIN15546P

PEXITAZ 500 POWDER FOR SOLUTION FOR INJECTION 500MG/VIAL

PEXITAZ 500 POWDER FOR SOLUTION FOR INJECTION 500MG/VIAL

September 21, 2018

RANBAXY (MALAYSIA) SDN. BHD.

RANBAXY (MALAYSIA) SDN. BHD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantRANBAXY (MALAYSIA) SDN. BHD.
Licence HolderRANBAXY (MALAYSIA) SDN. BHD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

INTRAVENOUS

Medical Information

L01BA04

pemetrexed

Manufacturer Information

RANBAXY (MALAYSIA) SDN. BHD.

SUN PHARMACEUTICAL INDUSTRIES LIMITED

Active Ingredients

Pemetrexed disodium heptahydrate 698.97mg eqv Pemetrexed

500.00 mg/vial

Pemetrexed

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.